Octagon Capital Advisors LP Gossamer Bio, Inc. Transaction History
Octagon Capital Advisors LP
- $263 Million
- Q2 2025
A detailed history of Octagon Capital Advisors LP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Octagon Capital Advisors LP holds 18,350,000 shares of GOSS stock, worth $58.4 Million. This represents 8.57% of its overall portfolio holdings.
Number of Shares
18,350,000
Previous 18,350,000
-0.0%
Holding current value
$58.4 Million
Previous $20.2 Million
11.82%
% of portfolio
8.57%
Previous 6.72%
Shares
11 transactions
Others Institutions Holding GOSS
# of Institutions
136Shares Held
159MCall Options Held
2.89MPut Options Held
130K-
Nea Management Company, LLC Timonium, MD18.1MShares$57.5 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$36.3 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$25.6 Million5.25% of portfolio
-
Acadian Asset Management LLC Boston, MA7.15MShares$22.7 Million0.02% of portfolio
-
683 Capital Management, LLC New York, NY6.34MShares$20.2 Million0.61% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $299M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...